Results 201 to 210 of about 471,997 (328)

The effect of proton-pump inhibitor therapy on disease outcomes in inflammatory bowel disease: a population-based cohort study. [PDF]

Therap Adv Gastroenterol
Deleuran T, Juul Poulsen G, Larsen L, Fallingborg J, Jepsen P, Jess T.   +5 more
europepmc   +1 more source

Dextran sodium sulfate confounds causal role of periodontitis in inflammatory bowel disease

Journal of Periodontology, EarlyView.
Abstract Background Emerging evidence supports a bidirectional link between periodontitis and inflammatory bowel disease (IBD). To investigate this relationship, experimental models commonly use dextran sodium sulfate (DSS) to induce colitis. However, DSS is presumed to selectively affect the colon, and its potential off‐target effects on the oral ...
Himanshi Tanwar, Jeba Mercy Gnanasekaran, Niyant Ganesh, Cindy Zhou, Amy Plotkin, Giacomo Baima, Massimo Costalonga, Fenfen Zhou, Hanping Feng, Priyam Jani, Jean‐Pierre Raufman, Vivek Thumbigere‐Math   +11 more
wiley   +1 more source

NCF2 as a Novel Diagnostic Biomarker in Ulcerative Colitis: Linking Macrophage Infiltration to Immune Dysregulation via Multi-Omics Analysis. [PDF]

J Inflamm Res
Zhang F, Zhu J, Liu H, Ye J, Li Y, Wang B.   +5 more
europepmc   +1 more source

Healthcare resource utilization and cost in pediatric celiac disease: A case‐control study using German insurance data

Journal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objectives Celiac disease (CeD) is a life‐long systemic immune‐mediated disorder. Data on burden and cost of CeD in children are scarce. We assessed healthcare resource utilization (HCRU) and cost of healthcare services of newly diagnosed children in Germany.
Sibylle Koletzko, Svitlana Schnaidt, Leonarda Serdani‐Neuhaus, Juliane Sünwoldt, Christina Dünweber, Bernd Bokemeyer   +5 more
wiley   +1 more source

Biomarkers of Probiotic Therapy in Ulcerative Colitis: A Systematic Review of Mechanisms Underlying Remission. [PDF]

Cureus
Farhad ME, Belal I, Baana M, Childs C, Al-Rufayie M.   +4 more
europepmc   +1 more source

Causal Relationship Between Inflammatory Bowel Disease and Neuropsychiatric Disorders: A Bidirectional Mendelian Randomization Study. [PDF]

Brain Behav
Lei J, Gong L, Wei S, Deng J.
europepmc   +1 more source

Drugs in focus: Budesonide and its role in paediatric gastrointestinal disorders

Journal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Budesonide is a glucocorticoid with strong topical anti‐inflammatory properties and minimal systemic effects due to extensive first‐pass hepatic metabolism. It is designed for targeted delivery within the gastrointestinal (GI) tract and is available in oral and rectal formulations.
Sohail Aziz, Maria Giovanna Puoti, Amit Assa, Zrinjka Misak, Emmanuel Mas, Osvaldo Borrelli, Jernej Dolinšek, Javier Martin‐de‐Carpi, Isabelle Scheers, Christos Tzivinikos, Matjaž Homan, Caterina Strisciuglio   +11 more
wiley   +1 more source

Response: Comments on "Role of 5-aminosalicylic acid in ulcerative colitis management in 8 Asian territories: a physician survey". [PDF]

Intest Res
Limsrivilai J, Leung WK.
europepmc   +1 more source

Correction to: Efficacy and Safety of Upadacitinib in a Case of Pediatric Acute Severe Ulcerative Colitis and Immune Thrombocytopenia. [PDF]

Inflamm Bowel Dis
europepmc   +1 more source

The diagnostic value of miR-340-5p in pediatric ulcerative colitis and its molecular mechanism by targeting MAP3K2 to modulate intestinal epithelial cell dysfunction. [PDF]

Hereditas
Meng F, Han X, Ge L, Guan N.
europepmc   +1 more source